PSNL logo

PSNL
Personalis Inc

2,779
Mkt Cap
$638.54M
Volume
2.44M
52W High
$11.50
52W Low
$3.62
PE Ratio
-6.71
PSNL Fundamentals
Price
$6.10
Prev Close
$5.90
Open
$5.90
50D MA
$7.36
Beta
2.14
Avg. Volume
1.69M
EPS (Annual)
-$0.9107
P/B
2.39
Rev/Employee
$267,876.92
$511.21
Loading...
Loading...
News
all
press releases
Personalis to Announce First Quarter 2026 Financial Results
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026. In...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research...
Business Wire·4d ago
News Placeholder
Personalis (NASDAQ:PSNL) Stock Price Down 6.2% - Here's What Happened
Personalis (NASDAQ:PSNL) Trading Down 6.2% - What's Next...
MarketBeat·5d ago
News Placeholder
Personalis (NASDAQ:PSNL) Shares Up 6.8% - What's Next?
Personalis (NASDAQ:PSNL) Trading 6.8% Higher - Should You Buy...
MarketBeat·12d ago
News Placeholder
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that an oral podium presentation featuring colorectal cancer data for the companys NeXT Personal...
Business Wire·12d ago
News Placeholder
Personalis (NASDAQ:PSNL) Stock Price Down 8.4% - Here's What Happened
Personalis (NASDAQ:PSNL) Shares Down 8.4% - Here's Why...
MarketBeat·18d ago
News Placeholder
Personalis, Inc. $PSNL Shares Acquired by Aberdeen Group plc
Aberdeen Group plc lifted its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 36.1% during the fourth quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·19d ago
News Placeholder
Personalis, Inc. (NASDAQ:PSNL) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold ra...
MarketBeat·20d ago
News Placeholder
Personalis to Participate in the 25th Annual Needham Virtual Conference
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be participating in the 25th Annual Needham Virtual Conference on...
Business Wire·24d ago
News Placeholder
Personalis (NASDAQ:PSNL) Trading Down 9.3% - Should You Sell?
Personalis (NASDAQ:PSNL) Trading Down 9.3% - Time to Sell...
MarketBeat·29d ago
<
1
2
...
>

Latest PSNL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.